手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| クローン病活動性指標× | ハーベイ・ブラッドショー指数（HBI）× | |
|---|---|---|
| 分野 | 消化器病学 | 消化器病学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1976 | 1980 |
| 提唱者≠ | Best, W. R., Becktel, J. M., Singleton, J. W., and Kern, F. | R. F. Harvey and J. M. Bradshaw |
| 種類 | Clinician-rated | Clinician-rated |
| 原典≠ | Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976). Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology, 70(3), 439–444. DOI ↗ | Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514. DOI ↗ |
| 別名 | CDAI | HBI |
| 関連≠ | 4 | 5 |
| 概要≠ | The Crohn's Disease Activity Index (CDAI) is a comprehensive, weighted index for assessing disease activity in Crohn's disease. Developed in 1976 by Best and colleagues for the National Cooperative Crohn's Disease Study, the CDAI integrates eight clinical and laboratory variables into a single score ranging from <150 (remission) to >450 (severe activity). Although more complex than symptom-based tools, the CDAI captures the multidimensional nature of Crohn's disease and remains the reference standard for severe disease assessment. | The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response. |
| ScholarGateデータセット ↗ |
|
|